ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA)

CUSIP: 29251M106

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
28,862,345
Total 13F shares
16,787,790
Share change
+185,170
Total reported value
$1,189,003,666
Put/Call ratio
77%
Price per share
$70.83
Number of holders
179
Value change
+$7,018,079
Number of buys
92
Number of sells
87

Quarterly Holders Quick Answers

What is CUSIP 29251M106?
CUSIP 29251M106 identifies ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q4 2018

As of 31 Dec 2018, ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) was held by 179 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,787,790 shares. The largest 10 holders included BlackRock Inc., Vanguard Group Inc, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, FARALLON CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, JANUS HENDERSON GROUP PLC, FIRST MANHATTAN CO, DIMENSIONAL FUND ADVISORS LP, and Krensavage Asset Management, LLC. This page lists 179 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.